Very Low Calorie Diet

OTHER19 trials

Sponsors

Rockefeller University, Columbia University, University of Rome Tor Vergata, Vanderbilt University, Indiana University

Conditions

DNA DamageDiabetes Mellitus Type 2 in ObeseDiabetic Kidney DiseaseIdiopathic Intracranial HypertensionInsulin ResistanceIntracranial PressureMorbid ObesityMuscle Loss

Phase 1

RYGB and the Gastric Adipose Axis

CompletedNCT01474785

Vanderbilt UniversityObesity

Start: 2012-01-31End: 2015-07-31Updated: 2018-05-21

Phase 2

Effects of Leptin Treatment on Weight Loss

CompletedNCT00050791

Rockefeller UniversityObesity

Start: 2001-03-31End: 2009-06-30Target: 40Updated: 2010-10-19

The Medically Reproducing Bariatric Surgery (MRB) II Study

Active, not recruitingNCT06363747

Durham VA Medical CenterObesity, Type 2 Diabetes

Start: 2024-06-24End: 2025-11-03Target: 50Updated: 2025-02-07

Phase 4

The Effect of an Anti-obesity Drug, Semaglutide, as Treatment in New-onset Idiopathic Intracranial Hypertension (IIH) Compared to Standard Weight Management (Dietician) With Regards to Change in Weight and Intracranial Pressure

CompletedNCT06027567

Rigmor Højland JensenIdiopathic Intracranial Hypertension, Intracranial Pressure, Obesity +3

Start: 2022-09-02End: 2025-10-28Updated: 2026-02-27

Unknown Phase

Changes in Insulin Sensitivity After Weight Loss

CompletedNCT00627484

Columbia UniversityInsulin Resistance, Obesity, Type 2 Diabetes Mellitus

Start: 2005-03-01End: 2018-06-17Updated: 2019-09-19

Caloric Restriction and Insulin Secretion

CompletedNCT01447524

University of Rome Tor VergataMorbid Obesity, Type 2 Diabetes Mellitus

Start: 2010-01-31End: 2011-03-31Updated: 2011-10-06

Very Low Calorie Diet for Diabetic Kidney Disease

CompletedNCT01671969

Indiana UniversityDiabetic Kidney Disease

Start: 2012-03-31End: 2014-03-31Updated: 2015-08-28

Gut Hormones and Roux en Y Gastric Bypass

RecruitingNCT01945840

Imperial College LondonObesity, Type 2 Diabetes

Start: 2013-10-31End: 2028-10-31Target: 190Updated: 2021-04-20

The Effect of a Short-term Very Low Calorie Diet on Heart Rate Variability in Obese Individuals

CompletedNCT02070770

King's College LondonObesity

Start: 2014-05-31End: 2015-05-31Updated: 2020-11-06

Effect of a Very Low Calorie and Low Calorie Diet on Moderate to Severe Obstructive Sleep Apnea in Obese Adults

CompletedNCT02251574

University of Kansas Medical CenterObstructive Sleep Apnea

Start: 2014-09-30End: 2016-06-30Updated: 2018-04-05

Impact of Body Weight and Weight Loss on Drug Bioavailability, Cardiovascular Risk Factors and Metabolic Biomarkers

Active, not recruitingNCT02386917

The Hospital of VestfoldObesity

Start: 2015-03-18End: 2028-12-31Target: 100Updated: 2024-10-02

Preservation of Fat Free Mass During Weight Loss

CompletedNCT03102372

University of AarhusMuscle Loss

Start: 2016-01-08End: 2016-05-02Updated: 2017-04-07

Omega-3 vs Very Low Calorie Diet for Liver Size Reduction

McMaster UniversityNAFLD, NASH - Nonalcoholic Steatohepatitis, Obesity +1

Start: 2019-01-01End: 2019-12-01Target: 60Updated: 2018-03-22

Utilization of Very Low Calorie Diet in Obese General Surgery Patients

CompletedNCT03553849

Christiana Care Health ServicesMorbid Obesity

Start: 2018-09-24End: 2020-12-31Updated: 2021-01-28

VLCD & Adjuvant Exercise Effect in Overweight Diabetic Men

CompletedNCT04957589

University of NottinghamDiabetes Mellitus Type 2 in Obese

Start: 2020-01-01End: 2022-12-01Updated: 2023-02-16

Changes in Anthropometric, Biochemical and DNA Damage Parameters After 3-weeks VLCD in Severely Obese Patients

CompletedNCT05007171

Special Hospital for Extended Treatment of Duga ResaDNA Damage, Obesity, Weight Loss

Start: 2019-06-14End: 2020-03-09Updated: 2021-08-16

Oxidative Stress and L-CBMN Cytome Assay in Obese After 3 Weeks VLCD

CompletedNCT05055154

Special Hospital for Extended Treatment of Duga ResaDNA Damage, Obesity, Weight Loss

Start: 2019-06-14End: 2020-11-03Updated: 2021-09-24

Acceptability and Feasibility of a Preoperative Very Low Calorie Diet Intervention on Surgical Weight Loss Outcomes (SAFETY)

Hartford HospitalObesity

Start: 2024-03-05End: 2025-12-30Target: 30Updated: 2024-02-28

Naltrexone/Bupropion With or Without Very Low Calorie Ketogenic Diet for Weight Regain After Bariatric Surgery

RecruitingNCT06881485

Universitaire Ziekenhuizen KU LeuvenObesity (Disorder), Weight Regain Post Bariatric Surgery

Start: 2025-01-20End: 2027-01-01Target: 62Updated: 2025-03-21

Related Papers

Gastric Bypass vs Diet and Cardiovascular Risk Factors: A Nonrandomized Controlled Trial.

2024-09-016 citations

Tripeptide gut hormone infusion does not alter food preferences or sweet taste function in volunteers with obesity and prediabetes/diabetes but promotes restraint eating: A secondary analysis of a randomized single‐blind placebo‐controlled study

Diabetes Obesity and Metabolism2023-02-226 citations

The postprandial secretion of peptide YY<sub>1‐36</sub> and <sub>3‐36</sub> in obesity is differentially increased after gastric bypass versus sleeve gastrectomy

Clinical Endocrinology2022-11-0811 citations

Impact of type 2 diabetes on in vivo activities and protein expressions of cytochrome <scp>P450</scp> in patients with obesity

Clinical and Translational Science2022-08-2916 citations

Correlations between 4β-hydroxycholesterol and hepatic and intestinal CYP3A4: protein expression, microsomal ex vivo activity, and in vivo activity in patients with a wide body weight range.

2022-06-0114 citations

Changes in anthropometric, biochemical, oxidative, and DNA damage parameters after 3-weeks-567-kcal-hospital-controlled-VLCD in severely obese patients with BMI ≥ 35 kg m<sup>-2</sup>.

2022-03-267 citations

The Metabolomic Effects of Tripeptide Gut Hormone Infusion Compared to Roux-en-Y Gastric Bypass and Caloric Restriction

The Journal of Clinical Endocrinology & Metabolism2021-08-3023 citations

Proglucagon peptide secretion profiles in type 2 diabetes before and after bariatric surgery: 1-year prospective study

BMJ Open Diabetes Research & Care2020-03-0127 citations

Impact of body weight, low energy diet and gastric bypass on drug bioavailability, cardiovascular risk factors and metabolic biomarkers: protocol for an open, non-randomised, three-armed single centre study (COCKTAIL)

BMJ Open2018-05-0125 citations

Very-low-calorie diet: a quick therapeutic tool to improve β cell function in morbidly obese patients with type 2 diabetes.

2012-02-0880 citations